BDX RSI

What is BDX?

Founded in 1897 by Maxwell Becton and Fairleigh Dickinson, BD started with a simple mission to improve medical outcomes. Over its long history, it has transformed from a small syringe manufacturer into a massive global leader in medtech. Headquartered in New Jersey, the company has hit major milestones, like creating the first American-made glass syringe and completing the massive 2017 acquisition of C.R. Bard, which really boosted their specialized medical tool portfolio.

The business model is all about being indispensable. They operate through three segments: BD Medical, BD Life Sciences, and BD Interventional. Their product list is huge, ranging from basic needles and catheters to advanced flow cytometry systems used in cancer research and those Pyxis automated cabinets you see in hospitals. Basically, if a patient is in a hospital, they are likely using a BD product. This creates a very stable revenue stream because most of these are disposable items that hospitals have to keep reordering.

Financially, BD is a favorite for dividend-focused investors. They are a Dividend Aristocrat, meaning they have raised their payout for over 50 years straight. While they took on significant debt for past acquisitions, they have been working hard to pay it down and lean out the business. They even spun off their diabetes care unit, Embecta, in 2022 to focus on higher-tech, higher-margin sectors like interventional surgery and molecular diagnostics.

Looking toward 2026, the strategy is built on their BD 2025 plan. They are going all-in on digital health, automation, and AI-integrated diagnostics. By 2026, they want to be the go-to for smart pharmacy tech and home-based care solutions. The goal is to hit steady mid-single-digit revenue growth while boosting profits through better supply chain efficiency and a focus on high-growth areas like immunology. They are shifting away from simple commodities and moving toward complex, data-driven clinical solutions.

What is RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and magnitude of price changes. Developed by J. Welles Wilder, RSI ranges from 0 to 100 and helps traders identify overbought or oversold conditions in an asset.

For BDX, monitoring the RSI provides valuable insights into potential trend reversals and entry/exit points. When the RSI drops below 30, Becton, Dickinson and Co. is typically considered oversold, suggesting the asset may be undervalued. Conversely, an RSI above 70 indicates overbought conditions.

Understanding BDX RSI Signals

• Oversold (RSI below 30): When BDX RSI falls below 30, it suggests the asset may have been sold off excessively and could be due for a bounce. This is often viewed as a potential buying opportunity, though it's important to consider other factors and not rely solely on RSI.
• Overbought (RSI above 70): An RSI above 70 indicates BDX may be overbought, potentially signaling a pullback or consolidation phase. Traders often use this as a signal to take profits or wait for better entry points.
• Divergences: When BDX price makes new highs or lows but RSI doesn't confirm these moves, it can signal weakening momentum and a possible trend reversal.

Daily vs Weekly RSI for BDX

This page displays both daily and weekly RSI for BDX. The daily RSI responds quickly to short-term price movements, making it useful for day traders and swing traders. The weekly RSI provides a broader perspective on momentum trends, helping longer-term investors identify major oversold or overbought conditions.

By analyzing both timeframes together, you can better understand Becton, Dickinson and Co.'s momentum at multiple levels and make more informed trading decisions.

Historical RSI Oversold Analysis

Above, we track historical instances when BDX RSI dropped below 30 (oversold territory). Reviewing these past oversold levels helps identify patterns and understand how Becton, Dickinson and Co. has historically responded to oversold conditions. Many traders use these historical reference points to gauge potential support levels and timing for entry positions.